AFP and hepatocellular carcinoma: In this study, the AFP promoter and enhancer restricted sr39 expression to AFP-producing HCC cell lines, with no off-target cell killing or radiotracer accumulation in non-HCC cells, including healthy human hepatocytes in vitro.